|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-1-18
|
|
pubmed:abstractText |
Up to 25% of inflammatory bowel disease (IBD) patients undergoing surgery with an ileal pouch-anal anastomosis (IPAA) will develop chronic pouchitis not responding to antibiotics. In case reports, thiopurine analogs and infliximab (IFX) have been proposed as effective therapy in this setting. We analyzed the long-term efficacy of IFX in Belgian patients with refractory pouch complications.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1536-4844
|
|
pubmed:author |
pubmed-author:BaertFilipF,
pubmed-author:Belgian IBD Research Group,
pubmed-author:D'HaensGeertG,
pubmed-author:De HertoghGertG,
pubmed-author:DewitOlivierO,
pubmed-author:FerranteMarcM,
pubmed-author:GeboesKarelK,
pubmed-author:HolvoetJanJ,
pubmed-author:RutgeertsPaulP,
pubmed-author:Van AsscheGertG,
pubmed-author:VermeireSéverineS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
243-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19637335-Adult,
pubmed-meshheading:19637335-Anti-Inflammatory Agents,
pubmed-meshheading:19637335-Antibodies, Monoclonal,
pubmed-meshheading:19637335-Belgium,
pubmed-meshheading:19637335-Crohn Disease,
pubmed-meshheading:19637335-Female,
pubmed-meshheading:19637335-Humans,
pubmed-meshheading:19637335-Male,
pubmed-meshheading:19637335-Middle Aged,
pubmed-meshheading:19637335-Postoperative Complications,
pubmed-meshheading:19637335-Pouchitis,
pubmed-meshheading:19637335-Time Factors,
pubmed-meshheading:19637335-Treatment Outcome,
pubmed-meshheading:19637335-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.
|
|
pubmed:affiliation |
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium. marc.ferrante@uz.kuleuven.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
